Germline HOXB13 p.Gly84Glu mutation and risk of colorectal cancer
Mohammad R Akbari, Laura N Anderson, Daniel D Buchanan, Mark Clendenning, Mark A Jenkins, Aung Ko Win, John L Hopper, Graham G Giles, Robert Nam, Steven Narod, Steven Gallinger, Sean P Cleary
CANCER EPIDEMIOLOGY | ELSEVIER SCI LTD | Published : 2013
Related Projects (1)
Awarded by National Cancer Institute, National Institutes of Health
Awarded by Ontario Registry for Studies of Familial Colorectal Cancer
Awarded by Australasian Colorectal Cancer Family Registry
This work was supported by the National Cancer Institute, National Institutes of Health under RFA # CA-95-011, the Ontario Registry for Studies of Familial Colorectal Cancer (U01 CA074783), the Australasian Colorectal Cancer Family Registry (U01 CA097735), and through cooperative agreements with members of the Colon Cancer Family Registry (CFRs) and P.I.s. The content of this manuscript does not necessarily reflect the views or policies of the National Cancer Institute or any of the collaborating centers in the CFRs, nor does mention of trade names, commercial products, or organizations imply endorsement by the US Government or the CFR.